HK Stock Market Move | YIDU TECH (02158) rose more than 3% against the market trend. YiduCore+DeepSeek landed at the Harbin Medical University Cancer Hospital.

YIDU TECH (02158) rose over 3% against the market trend, up 2.48% as the report was issued, trading at HK$6.62, with a turnover of HK$82.9733 million. Recently, YIDU TECH assisted Harbin Medical University Cancer Hospital in successfully deploying the Medical Crossing AI platform + DeepSeek locally. With the support of the domestic large model DeepSeek Full-blood version and the YiduCore "AI Medical Brain," the AI clinical guideline assistant was launched, providing intelligent guidance for diagnosis and treatment decisions. It is worth mentioning that this is another important landing and innovation breakthrough of "YiduCore + DeepSeek" after YIDU TECH's cooperation with top tertiary hospitals such as Xiangya Hospital of Central South University, The First Affiliated Hospital of Nanchang University, and Sun Yat-sen University Cancer Center. As of September 30, 2024, YIDU TECH's core algorithm engine YiduCore has processed and analyzed over 5.5 billion authorized medical records, covering a network of over 2,800 hospitals, with the disease knowledge graph covering almost all known diseases. The "General Intelligence Brain" DeepSeek-R1 Full-blood version, with 671 billion parameters, excels in task performance and generalization, and can flexibly adapt to various complex medical scenarios. With the support of the dual-brain system, doctors can diagnose and plan treatment more efficiently and accurately, develop personalized treatment strategies, greatly improving the efficiency and quality of diagnosis and treatment.